EurekaMag
+ Translate
+ Most Popular
Identification of compounds with anti-West Nile Virus activity
Geological age of the Ptilophyllum flora; a critical reassessment
Nira (Co 86032) - a new variety of sugarcane for Maharashtra
Occurrence of Eutrichophilus mexicanus (Rudow, 1866) and Eutrichophilus lobatus (Ewing, 1936) (Phthiraptera: Trichodectidae) on Sphiggurus villosus (Cuvier, 1825) (Rodentia: Erethizontidae) in Rio de
An assessment of water quality of river ganga at garhmukteshwar ghaziabad uttar pradesh india
The identity of the lipstick mold of cultivated mushrooms agaricus bisporus
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
Studies on feeding of tapioca thippi (tapioca or cassava starch waste) to swine
Effects of drum rolling on yield of summer groundnut
Integrated farming system for gardenland conditions of Coimbatore district - an over view
Influence of a decision analysis model on selection of drug therapy
Comparative performance of West Coast Tall and Lakshadweep Ordinary cultivars of coconut
Evaluation of WCT coconut and Komadan coconut
Cellars as hibernation sites for bats
Donkioporia expansa - A lesser known wood destroyer in buildings
The Bangla adaptation of Mini-Mental State Examination (BAMSE): An instrument to assess cognitive function in illiterate and literate individuals
Enterobacter amnigenus. An unusual human pathogen
'Rajeshwari' - a high-yielding white seeded variety of sesame for Andhra Pradesh
Gymnosperms of Sikkim, India
The great Coalinga cricket invasion
Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment
Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA
Classification of fermented foods: worldwide review of household fermentation techniques
The biology of human starvation: some new insights

List of PDF Full Texts available from EurekaMag Chapter 12409

Chapter 12409 contains a list of PDF Full Texts available from EurekaMag.




Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention
, Molecular Cancer Research: Mcr 4(3): 135-150 (2006)

Pharmacogenetics approach to therapeutics
, Clinical and Experimental Pharmacology and Physiology 33(5-6): 525-532 (2006)

Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
, Gut 55(10): 1423-1431 (2006)

Pharmacogenetics in cancer chemotherapy: balancing toxicity and response
, Therapeutic Drug Monitoring 26(2): 231-235 (2004)

Pharmacogenetics in drug development
, Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 360(1460): 1579-1588 (2005)

Pharmacogenetics in drug development: Regulatory and clinical considerations
, Drug Development Research 62(2): 102-111 (2004)

Pharmacogenetics in drug regulation: promise, potential and pitfalls
, Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 360(1460): 1617-1638 (2005)

Pharmacogenetics in gastrointestinal tumors
, Onkologie 28(8-9): 435-440 (2005)

Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers
, Progress in Neuro-Psychopharmacology and Biological Psychiatry 29(6): 1029-1037 (2005)

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives
, Transplantation 78(3): 311-315 (2004)

Pharmacogenetics in the rheumatic diseases
, Annals of the Rheumatic Diseases 63(Suppl): Ii25-Ii27 (2004)

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management
, Atherosclerosis 177(2): 219-234 (2004)

Pharmacogenetics of acenocoumarol pharmacodynamics
, Clinical Pharmacology and Therapeutics 75(5): 403-414 (2004)

Pharmacogenetics of anesthetic and analgesic agents
, Anesthesiology 102(3): 663-671 (2005)

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer
, Molecular Cancer Therapeutics 5(6): 1387-1395 (2006)

Pharmacogenetics of antihypertensive treatment
, Drug Development Research 62(3): 191-199 (2004)

Pharmacogenetics of antipsychotic-induced weight gain
, Pharmacological Research 49(4): 309-329 (2004)

Pharmacogenetics of autoimmune diseases: research issues in the case of Multiple Sclerosis and the role of IFN-beta
, Journal of Autoimmunity 25(Suppl): 1-5 (2005)

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 27(1): 54-61 (2006)

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
, Trends in Pharmacological Sciences 25(4): 193-200 (2004)

Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication
, European Journal of Clinical Investigation 33(Suppl): 17-22 (2003)

Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data
, Pharmacoepidemiology and Drug Safety 15(2): 99-105 (2006)

Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy
, Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 360(1460): 1563-1570 (2005)

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study
, Aids 18(18): 2391-2400 (2004)

Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 cases
, Onkologie 28(11): 589-592 (2005)

Pharmacogenetics of headache treatment
, Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 26(Suppl): S143-S147 (2005)

Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38
, Clinical Pharmacology and Therapeutics 76(6): 528-535 (2004)

Pharmacogenetics of irinotecan metabolism and transport: an update
, Toxicology in Vitro: An International Journal Published in Association with Bibra 20(2): 163-175 (2006)

Pharmacogenetics of irinotecan: a promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan
, Investigational new Drugs 23(6): 539-545 (2005)

Pharmacogenetics of lipid diseases
, Human Genomics 1(2): 111-125 (2004)

Pharmacogenetics of methylphenidate response in preschoolers with ADHD
, Journal of the American Academy of Child and Adolescent Psychiatry 45(11): 1314-1322 (2006)

Pharmacogenetics of multigenic disease: heart disease as an example
, Vascular Pharmacology 44(2): 66-74 (2006)

Pharmacogenetics of neoplastic diseases: new trends
, Pharmacological Research 49(4): 331-342 (2004)

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
, Blood 105(12): 4752-4758 (2005)

Pharmacogenetics of paraoxonases: a brief review
, Naunyn-Schmiedeberg's Archives of Pharmacology 369(1): 78-88 (2004)

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study
, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 42(3): 401-407 (2006)

Pharmacogenetics of psychotropic drug response
, American Journal of Psychiatry 161(5): 780-796 (2004)

Pharmacogenetics of soluble sulfotransferases (SULTs)
, Naunyn-Schmiedeberg's Archives of Pharmacology 369(1): 55-68 (2004)

Pharmacogenetics of the serotonin transporter
, Progress in Neuro-Psychopharmacology and Biological Psychiatry 29(6): 1062-1073 (2005)

Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy
, Therapeutic Drug Monitoring 26(2): 186-191 (2004)

Pharmacogenetics of thiopurine therapy in paediatric IBD patients
, Alimentary Pharmacology and Therapeutics 23(8): 1137-1141 (2006)

Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients
, Investigational New Drugs 22(3): 285-289 (2004)

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response
, European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 15(2): 143-151 (2005)

Pharmacogenetics/genomics and personalized medicine
, Human Molecular Genetics 14 Spec No. 2: R207-R214 (2005)

Pharmacogenetics: progress, pitfalls and clinical potential for coronary heart disease
, Vascular Pharmacology 44(2): 119-125 (2006)

Pharmacogenetics: towards personalized medicine
, Harefuah 144(10): 711 (2005)

Pharmacogenetics: yeast lead the way
, Chemistry and Biology 13(3): 236-238 (2006)

Pharmacogenetique et pharmacogenomie
, Bulletin du Cancer 93(Sp. Iss. SI): 113-123 (2006)

Pharmacogenomic approaches in antidiabetic drug development
, Drug Development Research 62(3): 207-212 (2004)

Pharmacogenomic approaches to therapies in rheumatic diseases
, Drug Development Research 62(3): 161-171 (2004)

Pharmacogenomic assessment of carboxylesterases 1 and 2
, Genomics 84(4): 661-668 (2004)

Pharmacogenomic genotyping methodologies
, Clinical Chemistry and Laboratory Medicine 42(11): 1256-1264 (2004)

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer
, Cancer Research 66(5): 2765-2777 (2006)

Pharmacogenomic identification of targets for adjuvant therapy with the topoisomerase poison camptothecin
, Cancer Research 64(6): 2096-2104 (2004)

Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy
, Free Radical Biology and Medicine 39(2): 152-163 (2005)

Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors
, International Journal of Oncology 24(4): 893-900 (2004)

Pharmacogenomical aspects of gastroesophageal reflux disease
, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(6): 33-36 (2005)

Pharmacogenomics and antidepressant drugs
, Annals of Medicine 38(2): 82-94 (2006)

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers
, European Journal of Pharmacology 527(1-3): 1-22 (2005)

Pharmacogenomics and systems biology of membrane transporters
, Molecular Biotechnology 29(1): 75-88 (2005)

Pharmacogenomics in admixed populations
, Trends in Pharmacological Sciences 26(4): 196-201 (2005)

Pharmacogenomics in cancer therapy: is host genome variability important?
, Trends in Pharmacological Sciences 25(9): 457-464 (2004)

Pharmacogenomics in cardiovascular clinical trials
, Fundamental and Clinical Pharmacology 18(6): 705-708 (2004)

Pharmacogenomics in cardiovascular medicine
, Drug Development Research 62(3): 180-190 (2004)

Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy
, Journal of Cellular Physiology 204(3): 742-749 (2005)

Pharmacogenomics in sepsis and septic shock
, Drug Development Research 64(4): 181-194 (2005)

Pharmacogenomics of antiretroviral therapy
, Drug Development Research 62(3): 213-220 (2004)

Pharmacogenomics of blood pressure response to antihypertensive treatment
, Journal of Hypertension 23(7): 1311-1325 (2005)

Pharmacogenomics of cholesterol-lowering therapy
, Vascular Pharmacology 44(2): 75-89 (2006)

Pharmacogenomics of colorectal cancer prevention and treatment
, Cancer Investigation 24(6): 630-639 (2006)

Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1)
, Biological and Pharmaceutical Bulletin 27(7): 939-948 (2004)

Pharmacogenomics of heart failure -- focus on drug disposition and action
, Cardiovascular Research 64(1): 32-39 (2004)

Pharmacogenomics of human OATP transporters
, Naunyn-Schmiedeberg's Archives of Pharmacology 372(6): 432-443 (2006)

Pharmacogenomics of osteoporosis: opportunities and challenges
, Journal of Musculoskeletal and Neuronal Interactions 6(1): 62-72 (2006)

Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice
, Pharmaceutical Research 23(11): 2621-2637 (2006)

Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes
, Clinical Pharmacology and Therapeutics 78(6): 635-646 (2005)

Pharmacogenomics of statin responsiveness
, American Journal of Cardiology 96(9a): 65k-70k; Discussion 34k-35k (2005)

Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design
, Die Naturwissenschaften 92(10): 451-463 (2005)

Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance
, Drug Development Research 62(3): 254-272 (2004)

Pharmacogenomics of thymidylate synthase in cancer treatment
, Frontiers in Bioscience: a Journal and Virtual Library 9: 2484-2494 (2004)

Pharmacogenomics, drug development, and ethics: Some points to consider
, Drug Development Research 62(2): 112-116 (2004)

Pharmacogenomics: Clinical and social implications
, Journal of Pharmacy Practice and Research 33(3): 224-227 (2003)

Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema
, Lymphatic Research and Biology 3(2): 81-86 (2005)

Pharmacogenomics: way to individual therapy
, Eksperimental'naia i Klinicheskaia Farmakologiia 68(5): 59-67 (2005)

Pharmacogenomics: from bedside to clinical practice
, Human Molecular Genetics 15 Spec no 1: R89-R93 (2006)

Pharmacognostic identification of Cryptolepis buchanaii
, Zhongguo Zhong Yao Za Zhi 29(7): 634-636 (2004)

Pharmacognostic investigation of leaves of Mitracarpus vilosus (SW) DC
, African Journal of Biotechnology 4(9): 957-959 (2005)

Pharmacognostic preliminary phytochemical studies on Hibiscus rosa-sinensis
, Indian Journal of Natural Products 21(4): 43-45 (2005)

Pharmacognostic standardization of Turnera aphrodisiaca Ward
, Journal of Medicinal Food 9(2): 254-260 (2006)

Pharmacognostic studies in some asteraceous ethnomedicinal plants of Korkus of Melghat, Dist. Amravati, (M.S.)
, BRI'S Journal of Advances in Science and Technology 5(1-2): 28-32 (2002)

Pharmacognostic studies on Asystasia gangetica (Acanthaceae)
, Journal of Phytological Research 18(2): 191-198 (2005)

Pharmacognostic studies on Desmodium gyrans
, Zhongguo Zhong Yao Za Zhi 30(3): 175-177 (2005)

Pharmacognostical evaluation of Arctii fructus (5) chemical constituents from fruits of Amorpha fruticosa
, Natural Medicines 58(6): 275-277 (2004)

Pharmacognostical evaluation of Cassia angustifolia seeds
, Pharmaceutical Biology 44(3): 202-207 (2006)

Pharmacognostical studies of cistanchis herba (IV) phylogenetic relationship of the Cistanche plants based on plastid rps2 gene and rpl16-rpl14 intergenic spacer region sequence
, Natural Medicines 57(6): 233-237 (2003)

Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction
, Circulation 109(21): 2480-2486 (2004)

Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol
, Biological and Pharmaceutical Bulletin 29(6): 1229-1233 (2006)

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model
, Anti-Cancer Drugs 15(6): 647-650 (2004)

Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice
, Journal of Pharmacy and Pharmacology 57(2): 177-181 (2005)

Pharmacokinetic advantages of two-hour post-dose cyclosporin a level for the therapeutic drug monitoring in stable Chinese kidney transplant recipients
, Nephron. Clinical Practice 99(3): C68-C72 (2005)

Pharmacokinetic analysis of advanced glycation end products (AGE)
, Yakugaku Zasshi 124(Suppl 4): 269-272 (2004)

Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 33(11): 1097-1108 (2003)

Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics. III: mechanisms for sinusoidal efflux of 4-methylumbelliferone sulfate
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 34(5): 439-448 (2004)

Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis
, Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 22(5): 347-352 (2006)

Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats
, Pharmaceutical Research 21(6): 1055-1064 (2004)

Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells
, Biological and Pharmaceutical Bulletin 29(3): 522-526 (2006)

Pharmacokinetic and behavioral effects of allopregnanolone in healthy women
, Psychopharmacology 186(3): 414-424 (2005)

Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis
, Pharmaceutical Research 21(11): 2072-2078 (2004)

Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease
, EJC Suppls 2(5): 9-12 (2004)

Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma
, Oncology 69(5): 363-371 (2005)

Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin
, Cancer ChemoTherapy and Pharmacology 57(5): 591-598 (2005)

Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
, Diabetologia 48(10): 1988-1995 (2005)

Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine
, Epilepsia 46(3): 378-384 (2005)

Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats
, Synapse 50(2): 110-116 (2003)

Pharmacokinetic and pharmacodynamic analysis of amprenavir-containing combination therapy in HIV-1-infected children
, Journal of Clinical Pharmacology 44(11): 1301-1308 (2004)

Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections
, International Journal of Antimicrobial Agents 28(Suppl): S35-S41 (2006)

Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms
, International Journal of Pharmaceutics 277(1-2): 141-153 (2004)

Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1
, British Journal of Clinical Pharmacology 57(2): 162-169 (2004)

Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses
, International Journal of Antimicrobial Agents 27(5): 409-416 (2006)

Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease
, Journal of Pharmacokinetics and Pharmacodynamics 32(3-4): 459-484 (2005)

Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children
, Journal of Clinical Endocrinology and Metabolism 89(7): 3234-3240 (2004)

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection
, Aids Research and Human Retroviruses 20(11): 1173-1182 (2004)

Pharmacokinetic and pharmacodynamic considerations in gene therapy
, Drug Discovery Today 8(21): 990-996 (2003)

Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins
, Journal of Controlled Release: Official Journal of the Controlled Release Society 112(3): 333-342 (2006)

Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers
, Journal of Clinical Pharmacology 44(1): 73-82 (2004)

Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics
, Pharmaceutical Research 22(12): 2035-2044 (2005 )

Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals
, Environmental Health Perspectives 113(9): 1243-1249 (2005)

Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation
, Bju International 97(2): 311-315 (2006)

Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs
, Journal of Cardiovascular Pharmacology 46(6): 863-869 (2005)

Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects
, Fundamental and Clinical Pharmacology 18(1): 113-123 (2004)

Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension
, Life Sciences 76(3): 281-292 (2004)

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 26(3-4): 295-306 (2005)

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers
, Journal of Clinical Pharmacology 44(9): 991-1002 (2004)

Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans
, Journal of Clinical Pharmacy and Therapeutics 31(5): 469-476 (2006)

Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions
, European Journal of Drug Metabolism and Pharmacokinetics 30(1-2): 121-126 (2005)

Pharmacokinetic and pharmacodynamic population modeling of orally administered rabeprazole in healthy Chinese volunteers by the NONMEM method
, European Journal of Drug Metabolism and Pharmacokinetics 31(1): 27-33 (2006)

Pharmacokinetic and pharmacodynamic profiles of BIA 3-202, a novel catechol-O-methyltransferase (COMT) inhibitor, during multiple-dose administration to healthy subjects
, Journal of Clinical Pharmacology 43(12): 1350-1360 (2003)

Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang)
, European Journal of Pharmacology 507(1-3): 163-168 (2005)

Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats
, Brain Research 1098(1): 71-78 (2006)

Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin
, Clinical Therapeutics 25(10): 2564-2574 (2003)

Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function
, Clinical Therapeutics 26(3): 390-398 (2004)

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers
, Clinical Therapeutics 28(1): 55-72 (2006)

Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs
, International Journal of Pharmaceutics 310(1-2): 46-52 (2006)

Pharmacokinetic and safety evaluation of high-dose combinations of fosamprenavir and ritonavir
, Antimicrobial Agents and ChemoTherapy 50(3): 928-934 (2006)

Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects
, Journal of Clinical Pharmacology 44(5): 520-531 (2004)

Pharmacokinetic and tissue distribution mechanism of mouse recombinant heat shock protein 70 in mice
, Pharmaceutical Research 22(3): 419-426 (2005)

Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: a pilot study
, Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 220(5): 338-342 (2006)

Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes
, IOVS Investigative Ophthalmology and Visual Science 44(11): 4895-4899 (2003)

Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent
, Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(11): 1946-1949 (2004)

Pharmacokinetic applications of capillary electrophoresis: a review on recent progress
, Electrophoresis 27(1): 257-265 (2006)

Pharmacokinetic aspects of biotechnology products
, Journal of Pharmaceutical Sciences 93(9): 2184-2204 (2004)

Pharmacokinetic aspects of evaluation of the efficacy and safety of pharmaceutical products
, Vestnik Dermatologii i Venerologii 3: 41-43 (2005)

Pharmacokinetic assessment of a fast-release orodispersible tramadol tablet compared to a conventional tramadol capsule
, Arzneimittel-Forschung 54(5): 293-297 (2004)

Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates
, Journal of Antimicrobial ChemoTherapy 54(1): 193-198 (2004)

Pharmacokinetic behavior and relative bioavailability of propylthiouracil sustained-release tablets vs market tablets in dogs
, Zhongguo Xinyao yu Linchuang Zazhi 24(7): 515-518 (2005)

Pharmacokinetic behavior and tissue distribution of verapamil and its enantiomers in rats by HPLC
, Archives of Pharmacal Research 26(9): 763-767 (2003)

Pharmacokinetic behavior in plasma, cerebrospinal fluid and cerebral cortex after intranasal administration of hydrochloride meptazinol
, Life Sciences 77(20): 2574-2583 (2005)

Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settings
, Therapeutic Drug Monitoring 27(6): 785-792 (2005)

Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration
, Biomaterials 26(26): 5368-5374 (2005)

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease
, Journal of Neural Transmission 113(10): 1441-1448 (2006)

Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes
, Archives of Pharmacal Research 27(7): 693-712 (2004)

Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
, Cancer ChemoTherapy and Pharmacology 57(5): 703-708 (2006)

Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 25(2-3): 337-345 (2005)

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate
, Biopharmaceutics and Drug Disposition 25(3): 137-142 (2004)

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin
, Journal of Pharmaceutical Sciences 93(9): 2374-2387 (2004)

Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats
, Biopharmaceutics and Drug Disposition 26(7): 309-320 (2005)

Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate
, Biopharmaceutics and Drug Disposition 27(7): 345-351 (2006)

Pharmacokinetic changes of irinotecan by intestinal alkalinization in an advanced colorectal cancer patient
, Therapeutic Drug Monitoring 27(4): 536-538 (2005)

Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine
, International Journal of Pharmaceutics 275(1-2): 227-238 (2004)

Pharmacokinetic characteristics of agents applied in the treatment of Parkinson's disease
, Journal of Neurology 253(Suppl 3): 53-59 (2006)

Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population
, Biological and Pharmaceutical Bulletin 28(10): 1934-1938 (2005 )

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection
, PharmacoTherapy 24(4): 453-459 (2004)

Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats
, Biopharmaceutics and Drug Disposition 24(8): 335-344 (2003)

Pharmacokinetic characterization of amantadine in human brain tissue
, Therapeutic Drug Monitoring 28(5): 693-695 (2006)

Pharmacokinetic characterization of dehydroevodiamine in the rat brain
, Journal of Pharmaceutical Sciences 93(2): 283-292 (2004)

Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers
, Biological and Pharmaceutical Bulletin 28(1): 114-119 (2005)

Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin
, Journal of ChemoTherapy 16(2): 193-200 (2004)

Pharmacokinetic comparison of Lamisil tablet and Muzonal tablet containing terbinafine HCl in healthy volunteers
, Yakhak Hoeji 49(4): 255-259 (2005)

Pharmacokinetic comparison of levofloxacin aspartate and other levofloxacin salts
, Zhongguo Kangshengsu Zazhi 30(8): 494-497 (2005)

Pharmacokinetic comparison of two methods of heroin smoking: 'chasing the dragon' versus the use of a heating device
, European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 15(3): 263-269 (2005)

Pharmacokinetic comparison of two recombinant human granulocyte colony-stimulating factor after subcutaneous administration in rabbits
, European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 61(3): 142-148 (2005)

Pharmacokinetic comparisons of Shuang-Huang-Lian with the different combinations of its constitutional herbs
, Journal of Ethnopharmacology 107(3): 401-405 (2006)

Pharmacokinetic consequences of active drug efflux at the blood-brain barrier
, Pharmaceutical Research 23(4): 705-717 (2006)

Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver model
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 36(5): 351-365 (2006)

Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients
, Biomedical Papers (Olomouc) 149(2): 309-313 (2005)

Pharmacokinetic detection of penicillin excreted in urine using a totally internally reflected resonance light scattering technique with cetyltrimethylammonium bromide
, Analytical and Bioanalytical Chemistry 382(1): 85-90 (2005)

Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy
, Transplantation Proceedings 37(4): 1739-1740 (2005)

Pharmacokinetic differences between pantoprazole enantiomers in rats
, Pharmaceutical Research 22(10): 1678-1684 (2005)

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes
, European Journal of Clinical Pharmacology 60(9): 623-628 (2004)

Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar
, International Journal of Clinical Pharmacology and Therapeutics 44(1): 1-7 (2006)

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice
, Journal of Acquired Immune Deficiency Syndromes 41(5): 563-572 (2006)

Pharmacokinetic drug interactions with nevirapine
, Journal of Acquired Immune Deficiency Syndromes 34(Suppl): S8-S14 (2003)

Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarol
, Investigational new Drugs 22(2): 151-158 (2004)

Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers
, Basic and Clinical Pharmacology and Toxicology 99(1): 33-36 (2006)

Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions
, Journal of Pharmaceutical Sciences 94(4): 718-729 (2005)

Pharmacokinetic evaluation and safety profile of a 15-minute versus 30-second infusion of palonosetron in healthy subjects
, Journal of Clinical Pharmacology 46(10): 1139-1145 (2006)

Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults
, Journal of Acquired Immune Deficiency Syndromes 35(4): 351-358 (2004)

Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol
, British Journal of Clinical Pharmacology 57(3): 270-278 (2004)

Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study
, International Journal of Pharmaceutics 270(1-2): 1-8 (2004)

Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug
, European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 58(3): 697-703 (2004)

Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men
, Journal of Clinical Endocrinology and Metabolism 90(5): 2624-2630 (2005)

Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz
, British Journal of Clinical Pharmacology 60(1): 32-34 (2005)

Pharmacokinetic interaction after joint administration of zinc and imipramine in forced swim test in mice
, Polish Journal of Pharmacology 56(4): 479-484 (2004)

Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats
, Journal of Pharmacy and Pharmacology 57(11): 1397-1405 (2005)

Pharmacokinetic interaction between Amprenavir/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation
, Transplantation Proceedings 38(4): 1138-1140 (2006)

Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol
, International Journal of Clinical Pharmacology and Therapeutics 44(3): 113-118 (2006)

Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients
, Journal of Antimicrobial ChemoTherapy 55(4): 546-549 (2005)

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation
, Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 18(11): 2409-2414 (2003)

Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers
, Biopharmaceutics and Drug Disposition 27(6): 285-289 (2006)

Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers
, International Journal of Clinical Pharmacology and Therapeutics 44(7): 326-330 (2006)

Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects
, Cancer ChemoTherapy and Pharmacology 54(4): 290-294 (2004)

Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108
, Aids 20(5): 725-729 (2006)

Pharmacokinetic interaction between oltipraz and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) after single intravenous and oral administration to rats
, Journal of Pharmacy and Pharmacology 55(9): 1241-1249 (2003)

Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients
, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(3): 426-429 (2004)

Pharmacokinetic interaction between verapamil and everolimus in healthy subjects
, British Journal of Clinical Pharmacology 60(4): 434-437 (2005)

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
, European Journal of Clinical Pharmacology 60(10): 709-715 (2004)

Pharmacokinetic interaction of ibuprofen enantiomers in rabbits
, Journal of Pharmacy and Pharmacology 56(3): 317-321 (2004)

Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users
, Biopharmaceutics and Drug Disposition 27(2): 61-68 (2005)

Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study
, Clinical Therapeutics 27(9): 1403-1410 (2005)

Pharmacokinetic interaction of tetracycline with non-steroidal anti-inflammatory drugs via organic anion transporters in rats
, Pharmacological Research 53(1): 75-79 (2006)

Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient
, British Journal of Clinical Pharmacology 59(5): 593-597 (2005)

Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults
, Epilepsia 47(11): 1830-1840 (2006)

Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers
, Journal of Clinical Pharmacology 45(2): 211-218 (2005)

Pharmacokinetic interaction with digoxin and glucocorticoids in rats detected by radio-immunoassay using a novel specific antiserum
, Life Sciences 77(9): 1055-1067 (2005)

Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all
, Aids 19(14): 1541-1543 (2005)

Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers
, Clinical Pharmacology and Therapeutics 78(2): 143-153 (2005)

Pharmacokinetic interactions between statins and fibrates
, American Journal of Cardiology 96(9a): 44k-49k; Discussion 34k-35k (2005)

Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers
, International Journal of Antimicrobial Agents 23(2): 144-149 (2004)

Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs
, Journal of Clinical Pharmacology 46(8): 855-866 (2006)

Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine
, International Journal of Clinical Pharmacology and Therapeutics 43(11): 527-535 (2005)

Pharmacokinetic investigation of aristolochic acid A in normal rats
, Fudan Xuebao 31(6): 562-564 (2004)

Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design
, Cancer ChemoTherapy and Pharmacology 54(3): 193-205 (2004)

Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients
, British Journal of Anaesthesia 95(3): 377-383 (2005)

Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma
, Rapid Communications in Mass Spectrometry: Rcm 19(24): 3617-3625 (2005)

Pharmacokinetic model for the enterohepatic circulation of mycophenolic acid
, Yao Xue Xue Bao 41(3): 272-276 (2006)

Pharmacokinetic model of R-roscovitine and its metabolite in healthy male subjects
, International Journal of Clinical Pharmacology and Therapeutics 42(4): 232-239 (2004)

Pharmacokinetic modeling of free amoxicillin concentrations in rat muscle extracellular fluids determined by microdialysis
, Antimicrobial Agents and ChemoTherapy 49(9): 3702-3706 (2005)

Pharmacokinetic modelling and simulation of the counter-transport in the hepatic transport of organic anions
, Yakhak Hoeji 49(4): 275-283 (2005)

Pharmacokinetic modelling of the interaction between St John's wort and ciclosporin A
, British Journal of Clinical Pharmacology 61(6): 671-676 (2006)

Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients
, European Journal of Clinical Pharmacology 59(11): 783-790 (2004)

Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 21(2-3): 217-223 (2004)

Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats
, Journal of Pharmacy and Pharmacology 56(6): 809-812 (2004)

Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving A quadruple immunosuppressive regimen: the value of C2 blood levels
, Transplantation 79(9): 1164-1168 (2005)

Pharmacokinetic parameter prediction from drug structure using artificial neural networks
, International Journal of Pharmaceutics 270(1-2): 209-219 (2004)

Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients
, Technology in Cancer Research and Treatment 4(3): 255-263 (2005)

Pharmacokinetic parameters and relative bioavailability of two tablet formulations of enalapril maleate
, Instrumentation Science and Technology 33(1): 1-8 (2005)

Pharmacokinetic parameters identification using the combined Alienor/Adomian methods
, Kybernetes 34(7-8): 1142-1158 (2005)

Pharmacokinetic parameters of bromperidol in Korean subjects
, Human Psychopharmacology 21(6): 409-412 (2006)

Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance
, Fundamental and Clinical Pharmacology 20(4): 397-403 (2006)

Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study
, Acta Paediatrica . Supplement 94(447): 61-8; Discussion 57 (2005)

Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study
, Journal of Clinical Pharmacology 46(2): 172-178 (2006)

Pharmacokinetic profile of tamsulosin OCAS
, BJU International 98(Suppl 2): 9-12 (2006)

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
, Journal of Clinical Pharmacology 45(5): 555-563 (2005)

Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations
, Antimicrobial Agents and ChemoTherapy 49(4): 1629-1632 (2005)

Pharmacokinetic profiles of huwentoxin-1 after epidural and intravenous administration in rats
, Zhongguo Yaolixue Yu Dulixue Zazhi 18(5): 344-351 (2004)

Pharmacokinetic profiles of two tablet formulations of piroxicam
, International Journal of Pharmaceutics 295(1-2): 129-134 (2005)

Pharmacokinetic profiling and bioequivalence assessment of two marketed brands of nevirapine tablets in healthy Indian volunteers
, Arzneimittel-Forschung 55(10): 598-603 (2005)

Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation
, Transplantation Proceedings 38(3): 751-752 (2006)

Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis
, Clinical Therapeutics 26(4): 493-501 (2004)

Pharmacokinetic properties and tolerability of single-dose terbutaline in patients with severe asthma treated in the pediatric intensive care unit
, Current Therapeutic Research Clinical and Experimental 65(1): 98-109 (2004)

Pharmacokinetic properties of a pasteurised fibrinogen concentrate
, Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 32(3): 239-246 (2005)

Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers
, Clinical Therapeutics 26(12): 2015-2025 (2004)

Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study
, Clinical Therapeutics 28(3): 419-427 (2006)

Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors
, Journal of Acquired Immune Deficiency Syndromes 37(Suppl): S2 (2004)

Pharmacokinetic properties of pravastatin in Mexicans: An open-label study in healthy adult volunteers
, Current Therapeutic Research Clinical and Experimental 66(3): 238-246 (2005)

Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis
, Pharmaceutical Research 22(12): 2016-2022 (2005)

Pharmacokinetic simulation of different modes of renal replacement therapy
, Anesteziologiya i Reanimatologiya 6: 16-23 (2004)

Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors
, Cancer ChemoTherapy and Pharmacology 54(6): 487-496 (2004)

Pharmacokinetic studies of a novel 1,2,4-thiadiazole derivative, inhibitor of Factor XIIIa, in the rabbit by a validated HPLC method
, Journal of Pharmaceutical and Biomedical Analysis 38(2): 293-297 (2005)

Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats
, Journal of Pharmaceutical Sciences 95(6): 1372-1381 (2006)

Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman
, Drug and Chemical Toxicology 27(2): 95-110 (2004)

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill
, Journal of Antimicrobial ChemoTherapy 55(3): 333-340 (2005)

Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome
, Journal of Clinical Endocrinology and Metabolism 91(4): 1246-1253 (2006)

Pharmacokinetic study and limited sampling strategy of cyclosporine in Japanese heart transplant recipients
, Circulation Journal: Official Journal of the Japanese Circulation Society 70(10): 1307-1311 (2006)

Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 28(3): 189-195 (2006)

Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species
, Free Radical Biology and Medicine 36(4): 517-525 (2004)

Pharmacokinetic study of benzoylmesaconine in rats using an enzyme immunoassay system
, Journal of Natural Medicines 60(4): 313-321 (2006)

Pharmacokinetic study of cancer chemotherapy
, Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 126(9): 723-735 (2006)

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 796(1): 189-194 (2003)

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients
, American Journal of Nephrology 25(4): 400-410 (2005)

Pharmacokinetic study of ibutilide injection in Chinese healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 25(7): 531-534 (2006)

Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles
, Zhonghua Zhong Liu Za Zhi 27(7): 412-415 (2005)

Pharmacokinetic study of ketoprofen in rat by blood microdialysis technique
, Yao Xue Xue Bao 41(5): 452-456 (2006)

Pharmacokinetic study of ketoprofen isopropyl ester-loaded lipid microspheres in rat blood using microdialysis
, Biological and Pharmaceutical Bulletin 29(4): 841-845 (2006)

Pharmacokinetic study of memantine in healthy and renally impaired subjects
, Clinical Pharmacology and Therapeutics 79(1): 134-143 (2006)

Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits
, Journal of Pharmaceutical Sciences 94(6): 1204-1215 (2005)

Pharmacokinetic study of novel recombinant human tumor necrosis factor-alpha (nrhTNF-alpha) in mice using ELISA
, Zhongguo Yaolixue Tongbao 21(7): 847-851 (2005)

Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 839(1-2): 118-123 (2006)

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer
, Farmaco 58(12): 1333-1338 (2003)

Pharmacokinetic study of p-coumaric acid in mouse after oral administration of extract of Ananas comosus L. leaves
, Biomedical Chromatography: Bmc 20(9): 951-955 (2006)

Pharmacokinetic study of promethazine in Korean healthy subjects using a validated HPLC method
, Journal of Applied Pharmacology 13(2): 118-122 (2005)

Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein
, Hepatology Research: the Official Journal of the Japan Society of Hepatology 30(3): 175-181 (2004)

Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily
, Journal of Antimicrobial ChemoTherapy 54(4): 785-790 (2004)

Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers
, Antimicrobial Agents and ChemoTherapy 49(2): 680-684 (2005)

Pharmacokinetic study of the new domestic prolonged form naltrexone - Depo-tablets prodetoxon
, Khimiko Farmatsevticheskii Zhurnal 39(1): 3-5 (2005)

Pharmacokinetic study of trimebutine maleate in rabbit blood using in vivo microdialysis coupled to capillary electrophoresis
, Journal of Pharmaceutical and Biomedical Analysis 39(3-4): 399-403 (2005)

Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation
, Biopharmaceutics and Drug Disposition 25(4): 149-156 (2004)

Pharmacokinetic variability of routinely administered bisoprolol in middle-aged and elderly Japanese patients
, Biological and Pharmaceutical Bulletin 28(5): 876-881 (2005)

Pharmacokinetic variability of sirolimus in Taiwanese renal transplant recipients
, Transplantation Proceedings 36(7): 2058-2059 (2004)

Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status
, Alimentary Pharmacology and Therapeutics 20(1): 29-36 (2004)

Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study
, Naunyn-Schmiedeberg's Archives of Pharmacology 373(4): 310-318 (2006)

Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis
, Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 10(2): 97-100 (2004)

Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery
, International Journal of Antimicrobial Agents 27(1): 15-19 (2006)

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly
, Clinical Pharmacology and Therapeutics 78(1): 69-80 (2005)

Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors
, Rheumatology 44(7): 846-859 (2005)

Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/carbidopa
, Clinical Neuropharmacology 27(1): 17-24 (2004)

Pharmacokinetic-pharmacodynamic modeling for the relationship between glucose-lowering effect and plasma concentration of metformin in volunteers
, Archives of Pharmacal Research 27(7): 806-810 (2004)

Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs
, Journal of Pharmacological and Toxicological Methods 53(2): 174-183 (2006)

Pharmacokinetic-pharmacodynamic modeling of irbesartan in healthy Chinese adult volunteers
, Zhongguo Yaolixue Tongbao 21(6): 712-715 (2005)

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics
, Journal of Pharmacology and Experimental Therapeutics 313(3): 1136-1149 (2005)

Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema
, IOVS Investigative Ophthalmology and Visual Science 45(10): 3435-3441 (2004)

Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model
, Pharmaceutical Research 22(11): 1769-1782 (2005)

Pharmacokinetic-pharmacodynamic modeling the hypnotic effect of sevoflurane using the spectral entropy of the electroencephalogram
, Anesthesia and Analgesia 102(1): 91-97 (2005)

Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
, British Journal of Clinical Pharmacology 61(2): 177-190 (2006)

Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models
, International Journal of Antimicrobial Agents 25(2): 120-129 (2005)

Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys
, Veterinary Research Communications 30(7): 775-789 (2006)

Pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemia
, Journal of Antimicrobial ChemoTherapy 54(1): 187-192 (2004)

Pharmacokinetic-pharmacodynamic modelling of the schedule-dependent effect of the anti-cancer agent CHS 828 in a rat hollow fibre model
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 25(1): 163-173 (2005)

Pharmacokinetic-pharmacodynamic modelling: history and perspectives
, Journal of Pharmacokinetics and Pharmacodynamics 33(3): 227-279 (2006)

Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats
, Naunyn-Schmiedeberg's Archives of Pharmacology 370(1): 1-8 (2004)

Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia
, Antimicrobial Agents and ChemoTherapy 50(3): 994-1000 (2006)

Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
, European Journal of Clinical Pharmacology 59(8-9): 603-609 (2003)

Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
, Pharmaceutical Research 22(7): 1088-1100 (2005)

Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form
, Infection 33(Suppl): 22-28 (2005)

Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by rhG-CSF in patients receiving antineoplastic drugs
, Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 124(9): 599-604 (2004)

Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia
, Journal of Pharmacology and Experimental Therapeutics 310(1): 202-208 (2004)

Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients
, Journal of Psychopharmacology 18(2): 221-227 (2004)

Pharmacokinetic/pharmacodynamic insulin-glucose analysis for differentiation of beta-cell function: an 18 month follow-up study in pre-pubertal lean and obese children
, Biopharmaceutics and Drug Disposition 27(6): 257-265 (2006)

Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients
, Diagnostic Microbiology and Infectious Disease 48(2): 125-130 (2004)

Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects
, Journal of Clinical Pharmacology 46(7): 747-757 (2006)

Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide
, Journal of Pharmacokinetics and Pharmacodynamics 33(4): 441-459 (2006)

Pharmacokinetic/pharmacodynamic modelling in oncological drug development
, Basic and Clinical Pharmacology and Toxicology 96(3): 206-211 (2005)

Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men
, European Journal of Clinical Pharmacology 60(5): 315-328 (2004)

Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain
, European Journal of Pharmacology 514(2-3): 131-140 (2005)

Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS
, British Journal of Clinical Pharmacology 58(4): 378-389 (2004 )

Pharmacokinetic/pharmacodynamic relationships for otamixaban, a direct factor Xa inhibitor, in healthy subjects
, Journal of Clinical Pharmacology 46(1): 45-51 (2006)

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
, Brazilian Journal of Medical and Biological Research 38(5): 683-694 (2005)

Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy
, Cancer ChemoTherapy and Pharmacology 54(4): 295-300 (2004)

Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK
, Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 33(2): 135-140 (2005)

Pharmacokinetics after intravenous, subcutaneous, and oral administration of enrofloxacin to alpacas
, American Journal of Veterinary Research 66(5): 767-771 (2005)

Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children
, Pediatric Infectious Disease Journal 24(10): 874-879 (2005)

Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits
, Veterinary Research Communications 28(6): 515-524 (2004)

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension
, Clinical Pharmacology and Therapeutics 76(6): 536-544 (2004)

Pharmacokinetics and a simulation model of colforsin daropate, new forskolin derivative inotropic vasodilator, in patients undergoing coronary artery bypass grafting
, Pharmacological Research 49(3): 275-281 (2004)

Pharmacokinetics and acute lethality of perfluorooctanesulfonate (PFOS) to juvenile mallard and northern bobwhite
, Archives of Environmental Contamination and Toxicology 50(3): 411-420 (2006)

Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women
, Journal of Clinical Pharmacology 45(2): 177-184 (2005)

Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study
, Oncology Reports 13(4): 589-595 (2005)

Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men
, Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(7): 677-684 (2003)

Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X
, Thrombosis and Haemostasis 90(5): 803-812 (2003)

Pharmacokinetics and bioavailability of a newly synthesized dihydropyridine compound with multidrug resistance reversal activity
, Biopharmaceutics and Drug Disposition 26(7): 279-285 (2005)

Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs
, European Journal of Drug Metabolism and Pharmacokinetics 31(1): 17-20 (2006)

Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients
, Therapeutic Drug Monitoring 27(3): 315-321 (2005)

Pharmacokinetics and bioavailability of sustained release and conventional formulation of acyclovir
, European Journal of Drug Metabolism and Pharmacokinetics 26(3): 145-148 (2001)

Pharmacokinetics and bioavailability of two kinds of gliclazide sustained-release tablets following a single and multiple dose in healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 24(5): 337-341 (2005)

Pharmacokinetics and bioavailability of two kinds of zidovudine capsules in Chinese healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 25(5): 321-325 (2006)

Pharmacokinetics and biodistribution of I-125 labeled rhTNT-IL2 in rats following a single intravenous injection
, Zhongguo Yaolixue Tongbao 21(8): 1013-1016 (2005)

Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice
, International Journal of Pharmaceutics 293(1-2): 281-290 (2005)

Pharmacokinetics and biodistribution of a pGT2-VEGF plasmid DNA after administration in rats
, Journal of Cardiovascular Pharmacology 46(5): 577-584 (2005)

Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123
, Acta Pharmacologica Sinica 27(6): 747-753 (2006)

Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice
, Journal of Pharmacology and Experimental Therapeutics 308(3): 1073-1082 (2003)

Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice
, Cancer ChemoTherapy and Pharmacology 57(5): 654-662 (2006)

Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques
, Biomedical Papers (Olomouc) 148(2): 161-166 (2004)

Pharmacokinetics and bioequiavalence assessment of Ginkgo biloba extract dropping pills and tablets
, Zhongguo Xinyao yu Linchuang Zazhi 24(12): 946-950 (2005)

Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers
, International Journal of Clinical Pharmacology and Therapeutics 42(3): 174-180 (2004)

Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes
, Archives of Pharmacal Research 29(6): 525-533 (2006)

Pharmacokinetics and bioequivalence of arginine ibuprofen syrup vs ibuprofen tablet in healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 25(1): 52-54 (2006)

Pharmacokinetics and bioequivalence of eperisone hydrochloride tablet in healthy subjects
, Yao Xue Xue Bao 39(4): 309-311 (2004)

Pharmacokinetics and bioequivalence of haloperidol tablet by liquid chromatographic mass spectrometry with electrospray ionization
, Archives of Pharmacal Research 28(4): 488-492 (2005)

Pharmacokinetics and bioequivalence of rabeprazole capsule and tablet
, Zhongguo Xinyao yu Linchuang Zazhi 24(5): 363-366 (2005)

Pharmacokinetics and bioequivalence of sertraline capsules and tablets
, Zhongguo Xinyao yu Linchuang Zazhi 25(1): 39-42 (2006)

Pharmacokinetics and bioequivalence of trimebutine dispersive tablet in healthy subjects
, Yao Xue Xue Bao 39(3): 208-211 (2004)

Pharmacokinetics and bioequivalence of two kinds of glucosamine indometacin enteric-coated tablets in Chinese male volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 24(2): 92-95 (2005)

Pharmacokinetics and bioequivalence study of a generic desloratadine tablet formulation in healthy male volunteers
, Arzneimittel-Forschung 54(3): 166-170 (2004)

Pharmacokinetics and bioequivalence study of amoxycillin and clavulanic acid (7: 1) a new combination in healthy male volunteers
, Zhongguo Kangshengsu Zazhi 28(11): 677-681 (2003)

Pharmacokinetics and bioequivalence study of sustained-release tablets and conventional capsules of cefaclor in healthy volunteers
, Zhongguo Kangshengsu Zazhi 30(9): 538-541 (2005)

Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography
, Analytica Chimica Acta 569(1-2): 145-150 (2006)

Pharmacokinetics and clearance processes of UK-279,276 (rNIF) in rat and dog: comparison with human data
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 36(4): 341-349 (2006)

Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses
, American Journal of Veterinary Research 67(9): 1484-1490 (2006)

Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces
, Photodermatology Photoimmunology and Photomedicine 21(2): 72-78 (2005)

Pharmacokinetics and comparative bioavailability of two diltiazem tablet formulations in healthy volunteers
, Daru 11(1): 14-18 (2003)

Pharmacokinetics and degree of aromatization rather than total dose of different preparations determine the effects of testosterone: a nonhuman primate study in Macaca fascicularis
, Journal of Andrology 24(5): 765-774 (2003)

Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys
, Arzneimittel-Forschung 55(3): 135-144 (2005)

Pharmacokinetics and disposition of silodosin (KMD-3213)
, Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 126 Spec No.: 237-245 (2006)

Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 33(10): 1555-1563 (2005)

Pharmacokinetics and distribution of sodium 3,4-diaminonaphthalene-1-sulfonate, a Congo Red derivative active in inhibiting PrP(res) replication
, Journal of Pharmacy and Pharmacology 56(3): 323-328 (2004)

Pharmacokinetics and distribution of superoxide dismutase liposomes in rats
, Yao Xue Xue Bao 40(2): 173-177 (2005)

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients
, Journal of Clinical Pharmacology 43(12): 1329-1340 (2003)

Pharmacokinetics and dosage regimen of furazolidone in poultry
, Indian Veterinary Journal 83(7): 722-725 (2006)

Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males
, Journal of Clinical Endocrinology and Metabolism 88(12): 5951-5956 (2003)

Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers
, Biopharmaceutics and Drug Disposition 25(6): 261-263 (2004)

Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study
, PharmacoTherapy 24(4): 468-476 (2004)

Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis
, Antimicrobial Agents and ChemoTherapy 48(12): 4631-4635 (2004)

Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease
, Journal of Hepatology 42(3): 365-370 (2005)

Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery
, British Journal of Anaesthesia 91(6): 830-835 (2003)

Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route
, Fertility and Sterility 84(1): 46-51 (2005)

Pharmacokinetics and excretion of dalbavancin in the rat
, Journal of Antimicrobial ChemoTherapy 55(Suppl): Ii31-Ii35 (2005)

Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure
, International Journal of Cardiology 91(2-3): 201-208 (2003)

Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey
, Journal of Pharmaceutical Sciences 95(11): 2499-2506 (2006)

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients
, Journal of Antimicrobial ChemoTherapy 55(2): 280-281 (2005)

Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice
, Cancer Immunology Immunotherapy: Cii 54(6): 535-547 (2005)

Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs
, International Journal of Pharmaceutics 325(1-2): 116-123 (2006)

Pharmacokinetics and individualized drug therapy
, Anales de la Real Academia Nacional de Farmacia 70(3): 663-679 (2004)

Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaemic patients on maintenance haemodialysis
, Journal of International Medical Research 32(1): 45-52 (2004)

Pharmacokinetics and metabolic disposition of sirolimus in healthy male volunteers after a single oral dose
, Therapeutic Drug Monitoring 28(1): 51-61 (2006)

Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico
, Biological and Pharmaceutical Bulletin 27(5): 706-709 (2004)

Pharmacokinetics and metabolism of 14C-1,3-dichloropropene in the Fischer 344 rat and the B6C3F1 mouse
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 34(2): 193-213 (2004)

Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers
, European Journal of Clinical Pharmacology 59(8-9): 621-630 (2003)

Pharmacokinetics and metabolism of NO-1886, a lipoprotein lipase-promoting agent, in cynomolgus monkey
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 33(12): 1247-1260 (2003)

Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: a rationale for long-lived plasma radioactivity
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 36(5): 399-418 (2006)

Pharmacokinetics and metabolism of a new potent antiepileptic drug, 2,2,3,3-tetramethycyclopropanecarbonylurea, in rats
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 33(10): 1538-1546 (2005)

Pharmacokinetics and metabolism of acriflavine in rats following intravenous or intramuscular administration of AG60, a mixture of acriflavine and guanosine, a potential antitumour agent
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 35(7): 755-773 (2005)

Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 33(1): 49-54 (2005)

Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer
, Anticancer Research 25(4): 2985-2990 (2005)

Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 32(5): 566-571 (2004)

Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: the female DA rat is not always an animal model for poor metabolizers of CYP2D6
, Journal of Pharmaceutical Sciences 94(2): 397-408 (2005)

Pharmacokinetics and metabolism of nicotine
, Pharmacological Reports: Pr 57(2): 143-153 (2005)

Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 32(9): 923-929 (2004)

Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 34(8): 1345-1352 (2006)

Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats
, Veterinary Journal 172(2): 302-307 (2006)

Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2
, Cancer ChemoTherapy and Pharmacology 55(1): 61-71 (2005)

Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis
, Journal of Antimicrobial ChemoTherapy 58(3): 693-696 (2006)

Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease
, Alimentary Pharmacology and Therapeutics 23(3): 387-396 (2006)

Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects
, Journal of Clinical Pharmacology 46(8): 876-886 (2006)

Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients
, Journal of Clinical Pharmacology 44(9): 1003-1011 (2004)

Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation
, Journal of Pharmaceutical Sciences 95(7): 1570-1585 (2006)

Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum
, Journal of Clinical Pharmacology 45(1): 25-33 (2004)

Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys
, Pharmaceutical Research 22(1): 58-61 (2005)

Pharmacokinetics and pharmacodynamics of a 0.1 mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia
, Anesthesia and Analgesia 102(3): 738-743 (2006)

Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers
, Anesthesia and Analgesia 103(2): 344-9 Table of Contents (2006)

Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75
, Journal of Clinical Pharmacology 44(5): 495-502 (2004)

Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers
, Journal of Clinical Pharmacology 45(11): 1236-1244 (2005)

Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention
, Journal of Clinical Pharmacology 44(9): 981-990 (2004)

Pharmacokinetics and pharmacodynamics of azosemide
, Biopharmaceutics and Drug Disposition 24(7): 275-297 (2003)

Pharmacokinetics and pharmacodynamics of benidipine using a slow receptor-binding model
, Journal of Clinical Pharmacy and Therapeutics 30(6): 541-547 (2005)

Pharmacokinetics and pharmacodynamics of carfentanil and naltrexone in female common eland (Taurotragus oryx)
, Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 37(3): 318-326 (2006)

Pharmacokinetics and pharmacodynamics of cefovecin in dogs
, Journal of Veterinary Pharmacology and Therapeutics 29(6): 501-511 (2006)

Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients
, Antimicrobial Agents and ChemoTherapy 49(2): 650-655 (2005)

Pharmacokinetics and pharmacodynamics of dauricine in beagle dogsl
, Zhongguo Yaolixue Tongbao 21(4): 464-467 (2005)

Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years
, European Journal of Clinical Pharmacology 60(6): 397-402 (2004)

Pharmacokinetics and pharmacodynamics of dexamethasone after intravenous administration in camels: effect of dose
, Veterinary Research Communications 28(6): 525-542 (2004)

Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients
, Journal of Trauma Injury Infection and Critical Care 59(6): 1336-1343 (2005)

Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses
, American Journal of Veterinary Research 67(10): 1687-1695 (2006)

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians
, Journal of Antimicrobial ChemoTherapy 53(Suppl): Ii23-Ii28 (2004)

Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity
, European Journal of Clinical Pharmacology 61(11): 791-795 (2005)

Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia
, Nucleosides Nucleotides and Nucleic Acids 23(8-9): 1119-1122 (2004)

Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients
, Basic and Clinical Pharmacology and Toxicology 98(1): 86-96 (2006)

Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients
, Antimicrobial Agents and ChemoTherapy 49(6): 2421-2428 (2005)

Pharmacokinetics and pharmacodynamics of injectable testosterone undecanoate in castrated cynomolgus monkeys (Macaca fascicularis) are independent of different oil vehicles
, Journal of Medical Primatology 34(4): 178-187 (2005)

Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancer
, Pediatric Blood and Cancer 47(5): 572-579 (2006)

Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects
, Antimicrobial Agents and ChemoTherapy 48(12): 4597-4605 (2004)

Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin
, Biopharmaceutics and Drug Disposition 26(8): 371-378 (2005)

Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen
, Cancer ChemoTherapy and Pharmacology 58(3): 292-305 (2006)

Pharmacokinetics and pharmacodynamics of levofloxacin in patients with respiratory tract infections using Bayesian forecasting
, Zhongguo Kangshengsu Zazhi 30(11): 689-692 (2005)

Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis
, Annals of PharmacoTherapy 39(3): 427-432 (2005)

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia
, Annals of PharmacoTherapy 39(1): 32-38 (2005)

Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion
, Journal of Clinical Pharmacology 43(12): 1324-1328 (2003)

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects
, PharmacoTherapy 24(9): 1110-1121 (2004)

Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate
, Journal of Pharmacology and Experimental Therapeutics 307(3): 1179-1187 (2003)

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA)
, Acta Anaesthesiologica Scandinavica 47(10): 1219-1225 (2003)

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase
, Anesthesiology 102(6): 1124-1132 (2005)

Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials
, Journal of Clinical Pharmacology 46(2): 179-192 (2006)

Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis
, Journal of Clinical Pharmacology 45(3): 286-298 (2005)

Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands
, Pharmaceutical Research 23(8): 1641-1658 (2006)

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites
, Clinical Pharmacology and Therapeutics 79(5): 461-479 (2006)

Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression
, Clinical Pharmacology and Therapeutics 75(1): 101-109 (2004)

Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
, Cancer Science 97(3): 235-241 (2006)

Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure
, European Journal of Anaesthesiology 22(1): 4-10 (2005)

Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity
, Pharmacological Research 50(1): 77-85 (2004)

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses
, Clinical Pharmacology and Therapeutics 78(6): 675-688 (2005)

Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects
, British Journal of Clinical Pharmacology 58(1): 40-51 (2004)

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
, Journal of Antimicrobial ChemoTherapy 58(2): 256-265 (2006)

Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans
, Clinical Pharmacology and Therapeutics 79(1): 49-61 (2006)

Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium
, Journal of Clinical Pharmacology 45(8): 919-926 (2005)

Pharmacokinetics and pharmacodynamics of weekly epoetin beta in lung cancer patients
, Japanese Journal of Clinical Oncology 36(8): 477-482 (2006)

Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays
, Journal of Clinical Pharmacy and Therapeutics 30(4): 319-328 (2005)

Pharmacokinetics and phototoxicity of purpurin-18 in human colon carcinoma cells using liposomes as delivery vehicles
, Cancer ChemoTherapy and Pharmacology 57(4): 500-506 (2005)

Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel
, Metabolism, Clinical and Experimental 54(10): 1276-1281 (2005)

Pharmacokinetics and reasonable clinical application of angiotensin II receptor antagonist
, Zhongguo Xinyao yu Linchuang Zazhi 23(2): 111-115 (2004)

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body
, Zhongguo Xinyao yu Linchuang Zazhi 23(11): 742-744 (2004)

Pharmacokinetics and relative bioavailability of domestic vs imported tizanidine tablets in human body
, Zhongguo Xinyao yu Linchuang Zazhi 23(7): 427-429 (2004)

Pharmacokinetics and relative bioavailability of gemfibrozil by HPLC determined in human being
, Zhongguo Xinyao yu Linchuang Zazhi 24(1): 29-32 (2005)

Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients
, British Journal of Clinical Pharmacology 58(4): 352-358 (2004)

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes
, British Journal of Clinical Pharmacology 61(6): 706-715 (2006)

Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers
, Aids 18(6): 897-907 (2004)

Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
, Investigational New Drugs 21(4): 445-452 (2003)

Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration
, European Journal of Clinical Pharmacology 62(7): 511-512 (2006)

Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms
, Archives of Dermatological Research 296(1): 6-11 (2004)

Pharmacokinetics and safety of intravitreally delivered etanercept
, Graefe's Archive for Clinical and Experimental Ophthalmology 242(7): 582-586 (2004)

Pharmacokinetics and safety of montelukast in children aged 3 to 6 months
, Journal of Clinical Pharmacology 46(6): 620-627 (2006)

Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers
, Clinical and Experimental Hypertension 28(7): 631-643 (2006)

Pharmacokinetics and safety of oral almotriptan in healthy male volunteers
, Biopharmaceutics and Drug Disposition 25(7): 303-311 (2004)

Pharmacokinetics and safety of solifenacin succinate in healthy young men
, Journal of Clinical Pharmacology 44(9): 1023-1033 (2004)

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332
, Journal of Infectious Diseases 190(12): 2167-2174 (2004)

Pharmacokinetics and safety of tanaproget, a nonsteroidal progesterone receptor agonist, in healthy women
, Contraception 74(5): 414-418 (2006)

Pharmacokinetics and safety of the MRI contrast agent gadoversetamide injection (OptiMARK) in healthy pediatric subjects
, Investigative Radiology 39(6): 334-339 (2004)

Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment
, Journal of Clinical Pharmacology 44(3): 234-244 (2004)

Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers
, Journal of Clinical Pharmacology 44(3): 265-275 (2004)

Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers
, Journal of Clinical Pharmacology 46(7): 715-726 (2006)

Pharmacokinetics and short-term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects
, Antimicrobial Agents and ChemoTherapy 49(7): 2802-2806 (2005)

Pharmacokinetics and splenic accumulation of N-acetylamino-3-chloro-N-(2-diethylamino-ethyl) benzamide after a single administration to rats
, Biopharmaceutics and Drug Disposition 25(7): 313-322 (2004)

Pharmacokinetics and stability properties of catalase modified with water-soluble polysaccharides
, Archiv der Pharmazie 339(7): 372-377 (2006)

Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women
, British Journal of Clinical Pharmacology 62(3): 288-296 (2006)

Pharmacokinetics and the active metabolite of enrofloxacin in Chinese mitten-handed crab (Eriocheir sinensis)
, Aquaculture 260(1-4): 69-76 (2006)

Pharmacokinetics and the cardiovascular effects of irbesartan in aortic coarctated rats
, Pharmacology 70(1): 23-30 (2004)

Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine
, Journal of Pharmaceutical Sciences 95(5): 985-997 (2006)

Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice
, Acta Pharmacologica Sinica 26(2): 250-256 (2005)

Pharmacokinetics and tissue distribution of gentiopicroside following oral and intravenous administration in mice
, European Journal of Drug Metabolism and Pharmacokinetics 29(3): 199-203 (2004)

Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 26(2): 194-202 (2005)

Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat
, Biopharmaceutics and Drug Disposition 26(5): 195-203 (2005)

Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion
, Journal of Drug Targeting 13(10): 543-553 (2005)

Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion
, Journal of Pharmaceutical Sciences 94(2): 437-445 (2005)

Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions
, Cancer ChemoTherapy and Pharmacology 52(5): 405-410 (2003)

Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 ((OC-6-43)bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV))
, International Journal of Pharmaceutics (Kidlington) 288(1): 123-129 (2005)

Pharmacokinetics and tissue distribution of the stereoisomers of 4-methylaminorex in the rat
, Journal of Pharmacology and Experimental Therapeutics 309(3): 1198-1205 (2004)

Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats
, Biopharmaceutics and Drug Disposition 24(8): 345-355 (2003)

Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes
, Die Pharmazie 60(11): 840-843 (2005)

Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals
, In Vivo 20(1): 91-96 (2006)

Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent
, Pharmaceutical Research 22(4): 596-602 (2005)

Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits
, Research in Veterinary Science 81(3): 366-372 (2006)

Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men
, European Journal of Endocrinology 150(1): 57-63 (2004)

Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain
, British Journal of Clinical Pharmacology 59(2): 249-253 (2005)

Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects
, British Journal of Clinical Pharmacology 61(4): 420-426 (2006)

Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
, Schizophrenia Research 70(1): 91-100 (2004)

Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms
, Clinical Pharmacology and Therapeutics 79(6): 570-580 (2006)

Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women
, European Journal of Clinical Pharmacology 61(7): 517-522 (2005)

Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women
, European Journal of Clinical Pharmacology 60(8): 569-574 (2004)

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation
, Nuclear Medicine and Biology 31(1): 11-19 (2004)

Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients
, Journal of Clinical Pharmacology 46(7): 727-737 (2006)

Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor
, Antimicrobial Agents and ChemoTherapy 48(12): 4835-4842 (2004)

Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting
, Cancer BioTherapy and Radiopharmaceuticals 18(6): 941-947 (2003)

Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis
, Journal of Investigative Dermatology 125(1): 68-71 (2005)

Pharmacokinetics of 0.5% levobupivacaine following ilioinguinal-iliohypogastric nerve blockade in children
, Acta Anaesthesiologica Scandinavica 49(3): 397-400 (2005)

Pharmacokinetics of 1-nitrosomelatonin and detection by EPR using iron dithiocarbamate complex in mice
, Biochemical Journal 387(Pt 2): 473-478 (2005)

Pharmacokinetics of 10 mg of mifepristone
, Contraception 68(6): 427-429 (2003)

Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats
, Archives of Pharmacal Research 28(4): 476-482 (2005)

Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses
, Oncology 66(1): 62-66 (2004)

Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model
, Japanese Journal of Clinical Oncology 33(8): 377-381 (2003)

Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin
, Biopharmaceutics and Drug Disposition 26(3): 93-98 (2005)

Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles
, Journal of Pharmaceutical Sciences 95(6): 1196-1211 (2006)

Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy
, Therapeutic Drug Monitoring 26(3): 311-318 (2004)

Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease
, Therapeutic Drug Monitoring 28(1): 45-50 (2006)

Pharmacokinetics of buspirone in autistic children
, Journal of Clinical Pharmacology 46(5): 508-514 (2006)

Pharmacokinetics of CPU0213, a novel endothelin receptor antagonist, after intravenous administration in mice
, Acta Pharmacologica Sinica 27(3): 367-371 (2006)

Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 27(4): 363-374 (2006)

Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect
, Antimicrobial Agents and ChemoTherapy 48(2): 659-662 (2004)

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats
, International Journal of Pharmaceutics 296(1-2): 94-102 (2005)

Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects
, Journal of Pharmaceutical Sciences 92(11): 2185-2195 (2003)

Pharmacokinetics of DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f, in tumor-bearing mice
, Die Pharmazie 59(5): 374-377 (2004)

Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation
, Journal of controlled release: official journal of the Controlled Release Society 110(1): 177-188 (2005)

Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function
, Journal of Clinical Pharmacology 43(12): 1361-1369 (2003)

Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys
, Acta Pharmacologica Sinica 26(1): 124-128 (2005)

Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis
, European Journal of Drug Metabolism and Pharmacokinetics 31(2): 109-116 (2006)

Pharmacokinetics of L-dopa - Special reference to food and aging
, Journal of Neurology 253(Suppl 3): 47-52 (2006)

Pharmacokinetics of L-dopa in plasma and extracellular fluid of striatum in common marmosets
, Brain Research 993(1-2): 54-58 (2003)

Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers
, Journal of Clinical Pharmacology 44(8): 901-905 (2004)

Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat
, Cancer ChemoTherapy and Pharmacology 58(4): 532-539 (2006)

Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients
, European Journal of Clinical Pharmacology 60(12): 859-864 (2005)

Pharmacokinetics of PEG-hemoglobin SB1, a hemoglobin-based oxygen carrier, after its intravenous administration in beagle dogs
, Archives of Pharmacal Research 27(2): 259-264 (2004)

Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats
, Journal of Photochemistry and Photobiology. B Biology 73(3): 183-188 (2004)

Pharmacokinetics of S(+) ketamine derived from target controlled infusion
, British Journal of Anaesthesia 96(3): 330-334 (2006)

Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer
, Oncology Reports 16(2): 361-366 (2006)

Pharmacokinetics of TJ-8117(Onpi-to), a drug for renal failure (II): effects of food, repeated administration and renal failure to plasma concentration of [3H]-(-)epicatechin 3-O-gallate in rats
, European Journal of Drug Metabolism and Pharmacokinetics 30(3): 175-180 (2005)

Pharmacokinetics of UH and LMWH are similar with respect to antithrombin activity
, Thrombosis Research 115(1-2): 45-51 (2005)

Pharmacokinetics of YM466, a new factor Xa inhibitor, in rats and dogs
, European Journal of Drug Metabolism and Pharmacokinetics 29(1): 7-13 (2004)

Pharmacokinetics of sifuvirtide in rats
, Zhongguo Yaolixue Yu Dulixue Zazhi 19(4): 296-299 (2005)

Pharmacokinetics of a cephalone (CQ-M-EPCA) in rats after oral, intraduodenal and intravenous administration
, International Journal of Pharmaceutics 282(1-2): 87-94 (2004)

Pharmacokinetics of a ginseng saponin metabolite compound K in rats
, Biopharmaceutics and Drug Disposition 27(1): 39-45 (2006)

Pharmacokinetics of a new Co-101 preparation studied by radionuclide method
, Khimiko Farmatsevticheskii Zhurnal 40(9): 5-6 (2006)

Pharmacokinetics of a new antitumor agent, 1-quinolin-4-ylamino)phenyl-ethanoe-O-methyl-oxime, in rat using a high performance liquid chromatography method
, Journal of Food and Drug Analysis 13(1): 38-42 (2005)

Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers
, Journal of Pharmacy and Pharmacology 56(4): 471-476 (2004)

Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers
, Drugs Under Experimental and Clinical Research 31(3): 115-121 (2005)

Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats
, Antimicrobial Agents and ChemoTherapy 50(5): 1869-1871 (2006)

Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range
, Journal of Clinical Pharmacology 46(11): 1308-1312 (2006)

Pharmacokinetics of a novel antiangiogenic agent KR-31831 in rats
, Biopharmaceutics and Drug Disposition 26(1): 21-26 (2005)

Pharmacokinetics of a novel c-Myc antisense phosphorothioate oligodeoxynucleotide in mice
, Zhongguo Xinyao yu Linchuang Zazhi 23(3): 136-138 (2004)

Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats
, Biopharmaceutics and Drug Disposition 27(2): 69-75 (2006)

Pharmacokinetics of a novel oral slow-release form of misoprostol
, Human Reproduction 20(12): 3414-3418 (2005)

Pharmacokinetics of a single bolus of propofol in chinese children of different ages
, Anesthesiology 104(1): 27-32 (2006)

Pharmacokinetics of a testosterone gel in healthy postmenopausal women
, Journal of Clinical Endocrinology and Metabolism 91(1): 136-144 (2006)

Pharmacokinetics of a triarylmethyl-type paramagnetic spin probe used in EPR oximetry
, Magnetic Resonance in Medicine 52(4): 885-892 (2004)

Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 31(11): 1419-1428 (2003)

Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses
, Journal of Veterinary Internal Medicine 20(3): 589-594 (2006)

Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations
, International Journal of Pharmaceutics 274(1-2): 201-211 (2004)

Pharmacokinetics of adefovir dipivoxil in monkeys and its distribution in rat tissues
, Zhongguo Yaolixue Yu Dulixue Zazhi 17(6): 447-450 (2003)

Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers
, Antimicrobial Agents and ChemoTherapy 48(5): 1553-1560 (2004)

Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease
, Journal of Clinical Pharmacology 45(3): 313-328 (2005)

Pharmacokinetics of alpha-naphthyl isothiocyanate in rats
, Journal of Pharmaceutical Sciences 94(11): 2441-2451 (2005)

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients
, Aids 17(18): 2669-2671 (2003)

Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients
, Therapeutic Drug Monitoring 28(1): 76-82 (2006)

Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs
, European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 60(1): 17-23 (2005)

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects
, Journal of Clinical Pharmacology 45(5): 570-577 (2005)

Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. extract
, Journal of Clinical Pharmacology 45(2): 203-210 (2005)

Pharmacokinetics of anthraquinones in rats after intragastric gavage of Taohechengqi decoction
, Zhongguo Yaolixue Tongbao 21(10): 1267-1270 (2005)

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years
, European Journal of Clinical Pharmacology 59(5-6): 411-415 (2003)

Pharmacokinetics of antivirals in neonate
, Early Human Development 81(9): 773-780 (2005)

Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers
, Journal of Clinical Pharmacology 46(3): 291-300 (2006)

Pharmacokinetics of aripiprazole and concomitant lithium and valproate
, Journal of Clinical Pharmacology 45(1): 89-93 (2005)

Pharmacokinetics of articaine hydrochloride in tumescent local anesthesia for liposuction
, Journal of Clinical Pharmacology 44(11): 1282-1289 (2004)

Pharmacokinetics of astragaloside IV in rabbits and its excretion in rats
, Zhongguo Xinyao yu Linchuang Zazhi 23(9): 563-567 (2004)

Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis
, Therapeutic Drug Monitoring 28(2): 219-225 (2006)

Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity
, Journal of ChemoTherapy 17(3): 315-320 (2005)

Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs
, Yao Xue Xue Bao 41(1): 24-29 (2006)

Pharmacokinetics of bromotetrandrin (W198) in rats and beagle dogs
, Yao Xue Xue Bao 39(4): 301-304 (2004)

Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study
, Nephron. Clinical Practice 97(3): C83-C89 (2004)

Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors
, Cancer ChemoTherapy and Pharmacology 54(3): 206-212 (2004)

Pharmacokinetics of cardiogreen in uterine myoma
, Uzbekiston Tibbiet Zhurnali 3: 45-47 (2005)

Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseases
, International Journal of Antimicrobial Agents 27(4): 331-334 (2006)

Pharmacokinetics of cefovecin in cats
, Journal of Veterinary Pharmacology and Therapeutics 29(6): 513-524 (2006)

Pharmacokinetics of cetirizine through healthy volunteers taking cetirizine and pseudoephedrine sustained-release tablets
, Zhongguo Xinyao yu Linchuang Zazhi 25(2): 84-87 (2006)

Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats
, Biological and Pharmaceutical Bulletin 28(3): 545-548 (2005)

Pharmacokinetics of chloramphenicol in carp (Cyprinus carpio L.) after drug administration
, Aquaculture Research 37(15): 1540-1545 (2006)

Pharmacokinetics of chlorhexidine gluconate 0.02% in the rabbit cornea
, Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 22(4): 227-230 (2006)

Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate
, Contraception 74(3): 239-244 (2006)

Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation
, Journal of Pharmaceutical Sciences 95(11): 2452-2462 (2006)

Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis
, Anticancer Research 24(3b): 2041-2045 (2004)

Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals
, American Journal of Veterinary Research 67(10): 1681-1686 (2006)

Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate
, Biopharmaceutics and Drug Disposition 25(6): 273-282 (2004)

Pharmacokinetics of clopidogrel after administration of a high loading dose
, Thrombosis and Haemostasis 92(2): 311-316 (2004)

Pharmacokinetics of combined doxorubicin and paclitaxel in mice
, Cancer Letters 220(2): 161-169 (2005)

Pharmacokinetics of compound famotidine chewing tablets
, Zhongguo Xinyao yu Linchuang Zazhi 25(7): 523-526 (2006)

Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma
, British Journal of Anaesthesia 94(1): 95-99 (2004)

Pharmacokinetics of controlled-release polymers in the subarachnoid space after subarachnoid hemorrhage in rabbits
, Journal of Neurosurgery 101(1): 99-103 (2004)

Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants
, Pharmacological Research 54(4): 287-292 (2006)

Pharmacokinetics of daptomycin in a critically ill adolescent with vancomycin-resistant enterococcal endocarditis
, PharmacoTherapy 26(5): 694-698 (2006 )

Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men
, Fertility and Sterility 81(3): 595-604 (2004)

Pharmacokinetics of dehydroevodiamine following intravenous administration in rats
, Korean Journal of Physiology and Pharmacology 8(1): 65-67 (2004)

Pharmacokinetics of deramciclane and N-desmethylderamciclane after single and repeated oral doses in healthy volunteers
, International Journal of Clinical Pharmacology and Therapeutics 42(8): 449-455 (2004)

Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults
, Journal of Clinical Pharmacology 46(10): 1204-1211 (2006)

Pharmacokinetics of dexketoprofen trometamol in subjects with mild and moderate chronic renal insufficiency
, Methods and Findings in Experimental and Clinical Pharmacology 28(Suppl): 21-28 (2006)

Pharmacokinetics of dibutylphthalate in pregnant rats
, Toxicological Sciences: An Official Journal of the Society of Toxicology 82(2): 407-418 (2004)

Pharmacokinetics of diclofenac in pigs after intramuscular administration of a single dose
, Acta Veterinaria Beograd 56(4): 323-331 (2006)

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin
, Biopharmaceutics and Drug Disposition 27(2): 85-92 (2006)

Pharmacokinetics of diclofenac sodium delayed-action preparation
, Zhongguo Xinyao yu Linchuang Zazhi 23(6): 342-345 (2004)

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life
, Pediatric Infectious Disease Journal 24(6): 503-509 (2005)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria
, European Journal of Clinical Pharmacology 62(5): 367-371 (2006)

Pharmacokinetics of domestic and imported meloxicam tablets following a single dose in healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 23(4): 195-198 (2004)

Pharmacokinetics of doxorubicin alginate microspheres and evaluation of its hepatic arterial embolization in vivo
, Yao Xue Xue Bao 41(8): 778-783 (2006)

Pharmacokinetics of enfuvirtide in a patient with impaired renal function
, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 39(11): E119-E121 (2004)

Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings
, Antimicrobial Agents and ChemoTherapy 50(2): 667-673 (2006)

Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus)
, Journal of Veterinary Pharmacology and Therapeutics 29(5): 397-402 (2006)

Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment
, Journal of Clinical Pharmacology 45(7): 810-821 (2005)

Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis
, Journal of Clinical Pharmacology 46(10): 1128-1138 (2006)

Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption
, Journal of Pharmacology and Experimental Therapeutics 311(1): 246-255 (2004)

Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: Role of P-glycoprotein as a barrier to in vivo ocular drug absorption (vol 311, pg 246, 2004)
, Journal of Pharmacology and Experimental Therapeutics 314(1): 483 (2005)

Pharmacokinetics of esomeprazole following varying intravenous administration rates
, Basic and Clinical Pharmacology and Toxicology 97(6): 351-354 (2005)

Pharmacokinetics of estradiol valerate and medroxyprogesterone acetate in different age groups of postmenopausal women
, Maturitas 47(3): 209-217 (2004)

Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study
, Clinical Neuropharmacology 26(6): 322-326 (2003)

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent
, Cancer Chemotherapy and Pharmacology 53(1): 91-93 (2004)

Pharmacokinetics of etoricoxib in patients with renal impairment
, Journal of Clinical Pharmacology 44(1): 48-58 (2004)

Pharmacokinetics of experimental pentavalent antimony after intramuscular administration in adult volunteers
, Current Therapeutic Research Clinical and Experimental 67(3): 193-203 (2006)

Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus
, ChemoTherapy 51(6): 370-376 (2005)

Pharmacokinetics of fluoxetine in elderly men and women
, Gerontology 52(1): 45-50 (2006)

Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers
, British Journal of Clinical Pharmacology 58(1): 20-25 (2004)

Pharmacokinetics of fudosteine in healthy volunteers
, Yaoxue Xuebao 40(10): 945-949 (2005)

Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
, Epilepsia 46(10): 1621-1624 (2005)

Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures
, Journal of Clinical Pharmacy and Therapeutics 29(6): 511-515 (2004)

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment
, Journal of Antimicrobial ChemoTherapy 57(5): 1004-1007 (2006)

Pharmacokinetics of gatifloxacin in infants and children
, Antimicrobial Agents and ChemoTherapy 49(3): 1106-1112 (2005)

Pharmacokinetics of gatifloxacin mesylate and gatifloxacin in rats in vivo
, Zhongguo Yaolixue Tongbao 22(6): 751-754 (2006)

Pharmacokinetics of gatifloxacin mesylate tablets in healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 23(9): 586-588 (2004)

Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 34(10): 901-915 (2004)

Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer
, Onkologie 28(6-7): 318-322 (2005)

Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia
, Journal of Clinical Pharmacology 44(8): 873-880 (2004)

Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats
, Analytical Biochemistry 323(2): 156-163 (2003)

Pharmacokinetics of glyprolines (PGP) upon intragastric administration
, Eksperimental'naia i Klinicheskaia Farmakologiia 67(4): 57-60 (2004)

Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats
, Clinical and Experimental Pharmacology and Physiology 32(1-2): 13-18 (2005)

Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts
, Clinical Pharmacology and Therapeutics 74(4): 341-352 (2003)

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block
, Drug and Alcohol Dependence 72(1): 75-83 (2003)

Pharmacokinetics of high-molecular-weight poly(ethylene oxide)
, Khimiko Farmatsevticheskii Zhurnal 40(9): 7-8 (2006)

Pharmacokinetics of hylotelephin in Beagle dogs
, Yao Xue Xue Bao 41(7): 680-683 (2006)

Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulation
, International Journal of Clinical Pharmacology and Therapeutics 43(3): 140-149 (2005)

Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study
, Cancer ChemoTherapy and Pharmacology 56(4): 358-360 (2005)

Pharmacokinetics of imipenem in healthy volunteers following administration by 2 h or 0.5 h infusion
, Journal of Antimicrobial ChemoTherapy 56(6): 1163-1165 (2005)

Pharmacokinetics of immunosuppressants: a perspective on ethnic differences
, International Journal of Clinical Pharmacology and Therapeutics 42(12): 701-718 (2004)

Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects
, Antimicrobial Agents and ChemoTherapy 48(3): 918-923 (2004)

Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients
, Antimicrobial Agents and ChemoTherapy 48(11): 4200-4208 (2004)

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus
, Antimicrobial Agents and ChemoTherapy 48(11): 4476-4478 (2004)

Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children
, Antimicrobial Agents and Chemotherapy 48(5): 1904-1907 (2004)

Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients
, Aids 18(3): 565-567 (2004)

Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects
, Journal of Acquired Immune Deficiency Syndromes 34(2): 134-139 (2003)

Pharmacokinetics of indomethacin, a metabolite of acemetacin, following a single dose and multiple doses administered as acemetacin sustained-release tablets in healthy male volunteers
, Journal of Health Science 51(3): 308-316 (2005)

Pharmacokinetics of inhaled anesthetics in green iguanas (Iguana iguana)
, American Journal of Veterinary Research 67(10): 1670-1674 (2006)

Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
, Journal of Antimicrobial ChemoTherapy 57(2): 306-311 (2006)

Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients
, International Journal of Artificial Organs 28(8): 808-816 (2005)

Pharmacokinetics of intrathecal oligodeoxynucleotides
, Anesthesiology 100(2): 315-322 (2004)

Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise
, European Journal of Clinical Pharmacology 60(10): 717-723 (2004)

Pharmacokinetics of intravenous immunoglobulin: a systematic review
, PharmacoTherapy 26(6): 813-827 (2006)

Pharmacokinetics of intravenous paracetamol in children and adolescents under major surgery
, European Journal of Clinical Pharmacology 60(12): 883-888 (2005)

Pharmacokinetics of intravenous rifampicin (rifampin) in neonates
, Therapeutic Drug Monitoring 28(5): 654-661 (2006)

Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment
, Journal of Clinical Pharmacology 44(2): 163-172 (2004)

Pharmacokinetics of intravenously administered azithromycin in pediatric patients
, Pediatric Infectious Disease Journal 24(1): 34-39 (2005)

Pharmacokinetics of intravenously administered levofloxacin in men and women
, PharmacoTherapy 25(10): 1310-1318 (2005)

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
, European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 62(1): 44-51 (2006)

Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs
, Acta Ophthalmologica Scandinavica 83(2): 184-190 (2005)

Pharmacokinetics of ketorolac pentyl ester, a novel ester derivative of ketorolac, in rabbits
, Kaohsiung Journal of Medical Sciences 21(8): 365-370 (2005)

Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats
, Biopharmaceutics and Drug Disposition 27(2): 53-59 (2006)

Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes
, Acta Pharmacologica Sinica 25(8): 986-990 (2004)

Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests
, Clinical Pharmacology and Therapeutics 77(6): 529-541 (2005)

Pharmacokinetics of levobupivacaine 0.25% following caudal administration in children under 2 years of age
, British Journal of Anaesthesia 92(2): 218-222 (2004)

Pharmacokinetics of levobupivacaine after caudal epidural administration in infants less than 3 months of age
, British Journal of Anaesthesia 95(4): 524-529 (2005)

Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators
, European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 23(3): 213-222 (2004)

Pharmacokinetics of liposomal amphotericin B during extracorporeal albumin dialysis
, Artificial Organs 30(2): 118-121 (2006)

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study
, Cancer ChemoTherapy and Pharmacology 54(6): 514-524 (2004)

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation
, Cancer ChemoTherapy and Pharmacology 56(5): 492-496 (2005)

Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment
, Journal of Clinical Pharmacology 45(11): 1259-1267 (2005)

Pharmacokinetics of lopinavir after administration of Kaletra in healthy Japanese volunteers
, Biological and Pharmaceutical Bulletin 27(2): 261-265 (2004)

Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment
, Journal of Clinical Pharmacology 46(3): 265-274 (2006)

Pharmacokinetics of lorazepam injection in Chinese healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 24(10): 785-788 (2005)

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
, Cancer ChemoTherapy and Pharmacology 55(5): 488-496 (2005)

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile
, Pharmacopsychiatry 37(4): 180-188 (2004)

Pharmacokinetics of m-nifedipine in Beagle dogs
, Yao Xue Xue Bao 39(8): 609-612 (2004)

Pharmacokinetics of magnesium isoglycyrrhizinate after a single and multiple intravenous dose in healthy volunteers
, Zhongguo Xinyao yu Linchuang Zazhi 24(2): 85-89 (2005)

Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains
, Journal of Dairy Science 87(1): 202-211 (2004)

Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats
, Biopharmaceutics and Drug Disposition 25(4): 187-191 (2004)

Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis
, Journal of Clinical Pharmacology 44(8): 866-872 (2004)

Pharmacokinetics of meropenem in the patients with burn injury
, Zhongguo Kangshengsu Zazhi 29(2): 118-123 (2004)

Pharmacokinetics of methotrexate in rabbit skin and plasma after iv-bolus and iontophoretic administrations
, Journal of Controlled Release: Official Journal of the Controlled Release Society 93(3): 283-292 (2003)

Pharmacokinetics of methylamine and its metabolite formaldehyde in animals
, Zhongguo Yaolixue Yu Dulixue Zazhi 20(2): 120-124 (2006)

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects
, European Journal of Clinical Pharmacology 60(4): 231-236 (2004)

Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk
, Clinical Pharmacology and Therapeutics 79(6): 549-557 (2006)

Pharmacokinetics of minocycline hydrochloride for injection in healthy human
, Zhongguo Kangshengsu Zazhi 31(1): 33-35 (2006)

Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion
, Journal of ChemoTherapy 17(6): 668-673 (2005)

Pharmacokinetics of modified oral calcitonin product in healthy volunteers
, Pharmacotherapy 24(8): 994-1001 (2004)

Pharmacokinetics of monobutylphthalate, the active metabolite of di-n-butylphthalate, in pregnant rats
, Toxicology Letters 159(2): 144-153 (2005)

Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old
, Journal of Clinical Pharmacology 44(5): 487-494 (2004)

Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration
, Journal of Antimicrobial ChemoTherapy 54(4): 780-784 (2004)

Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency
, Transplantation Proceedings 37(9): 3749-3751 (2006)

Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients
, Therapeutic Drug Monitoring 28(1): 95-101 (2006)

Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine
, Transplantation Proceedings 37(2): 864-866 (2005)

Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil
, Journal of the Medical Association of Thailand 86(8): 766-771 (2003)

Pharmacokinetics of natural progesterone vaginal suppository
, Gynecologic and Obstetric Investigation 58(2): 105-108 (2004)

Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors
, Antimicrobial Agents and ChemoTherapy 49(8): 3558-3561 (2005)

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
, British Journal of Clinical Pharmacology 62(3): 309-315 (2006)

Pharmacokinetics of nelfinavir in subjects with hepatic impairment
, Journal of Clinical Pharmacology 46(11): 1241-1249 (2006)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
, Aids 19(14): 1495-1499 (2005)

Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism
, Journal of Pharmacology and Experimental Therapeutics 311(2): 659-667 (2004)

Pharmacokinetics of ofloxacin in drug-resistant tuberculosis
, Journal of the Medical Association of Thailand 86(8): 781-788 (2003)

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers
, Journal of Clinical Pharmacology 46(2): 164-171 (2006)

Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects
, Clinical Drug Investigation 26(1): 29-34 (2006)

Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours
, Biopharmaceutics and Drug Disposition 26(2): 77-83 (2005)

Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats
, Journal of Pharmaceutical Sciences 95(5): 998-1005 (2006)

Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin
, Life Sciences 78(20): 2287-2294 (2006)

Pharmacokinetics of omeprazole in healthy adults and in children with gastroesophageal reflux disease
, Therapeutic Drug Monitoring 26(1): 3-8 (2004)

Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction
, Methods and Findings in Experimental and Clinical Pharmacology 25(8): 625-630 (2003)

Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications
, Aids 19(10): 1105-1107 (2005)

Pharmacokinetics of oral amlodipine orotate in vagotomized dogs
, Biopharmaceutics and Drug Disposition 27(3): 141-145 (2006)

Pharmacokinetics of oral antitumor drug satraplatin in rats
, Zhongguo Xinyao yu Linchuang Zazhi 23(8): 528-530 (2004)

Pharmacokinetics of oral fumarates in healthy subjects
, British Journal of Clinical Pharmacology 58(4): 429-432 (2004)

Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose
, Antimicrobial Agents and ChemoTherapy 49(1): 148-152 (2004)

Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure
, Journal of Clinical Pharmacology 46(1): 37-44 (2006)

Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigation
, International Journal of Clinical Pharmacology and Therapeutics 44(3): 128-134 (2006)